Advance your academic career, collaborate globally, and expand your network— join now !

Dorota Bartusik-Aebisher

Prof. Dr. Dorota Bartusik-Aebisher

Department of Biochemistry and General Chemistry, University of Rzeszów, 35-310 ...

Share Link

Share

Information

Prof. Dorota Bartusik-Aebisher works at the University of Rzeszow in Poland and obtained a doctorate in organic chemistry at the Warsaw University of Technology. Her research focuses on the applications of MRI to cancer treatments. Her research interests are the applications of 19F MR to drug tracking and visualization of cancer tissue. She worked intensively on new drug delivery systems for ovarian cancer cells OVCAR-5 in cooperation with Harvard Medical School in Boston and The City University of New York (CUNY, NY, USA). She completed her Ph.D. at the Warsaw University of Technology, Warsaw, Poland. She obtained a habilitation degree in medical sciences in medical biology (Warsaw Medical University, Warsaw, Poland). She is coauthor of over 200 research papers and 12 books related to drug design and medical biology.

Research Keywords & Expertise

Drug Delivery
Molecular Imaging
magnetic resonance ima...
magnetic resonance spe...
Breast cancer treatmen...

Short Biography

Prof. Dorota Bartusik-Aebisher works at the University of Rzeszow in Poland and obtained a doctorate in organic chemistry at the Warsaw University of Technology. Her research focuses on the applications of MRI to cancer treatments. Her research interests are the applications of 19F MR to drug tracking and visualization of cancer tissue. She worked intensively on new drug delivery systems for ovarian cancer cells OVCAR-5 in cooperation with Harvard Medical School in Boston and The City University of New York (CUNY, NY, USA). She completed her Ph.D. at the Warsaw University of Technology, Warsaw, Poland. She obtained a habilitation degree in medical sciences in medical biology (Warsaw Medical University, Warsaw, Poland). She is coauthor of over 200 research papers and 12 books related to drug design and medical biology.